321 related articles for article (PubMed ID: 34575511)
1. Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer.
Gaurav I; Wang X; Thakur A; Iyaswamy A; Thakur S; Chen X; Kumar G; Li M; Yang Z
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575511
[TBL] [Abstract][Full Text] [Related]
2. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy.
Tiwari P; Yadav K; Shukla RP; Gautam S; Marwaha D; Sharma M; Mishra PR
J Control Release; 2023 Nov; 363():290-348. PubMed ID: 37714434
[TBL] [Abstract][Full Text] [Related]
3. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
Prasad R; Conde J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications.
Wang Y; Zhang X; Wan K; Zhou N; Wei G; Su Z
J Nanobiotechnology; 2021 Aug; 19(1):253. PubMed ID: 34425823
[TBL] [Abstract][Full Text] [Related]
5. Peptide-functionalized delivery vehicles for enhanced cancer therapy.
Tang SY; Wei H; Yu CY
Int J Pharm; 2021 Jan; 593():120141. PubMed ID: 33279713
[TBL] [Abstract][Full Text] [Related]
6. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
7. Production, surface modification and biomedical applications of nanodiamonds: A sparkling tool for theranostics.
Tinwala H; Wairkar S
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():913-931. PubMed ID: 30678981
[TBL] [Abstract][Full Text] [Related]
8. Functionalized nano-targeted moieties in management of prostate cancer.
Salaheldin TA; Bharali DJ; Mousa SA
Future Oncol; 2020 May; 16(13):869-883. PubMed ID: 32292071
[TBL] [Abstract][Full Text] [Related]
9. Integrin Facilitates the Internalization of TAT Peptide Conjugated to RGD Motif in Model Lipid Membranes.
Ciobanasu C; Pernier J; Le Clainche C
Chembiochem; 2024 Jan; 25(2):e202300642. PubMed ID: 37947251
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
Imani R; Emami SH; Faghihi S
Phys Chem Chem Phys; 2015 Mar; 17(9):6328-39. PubMed ID: 25650242
[TBL] [Abstract][Full Text] [Related]
11. Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review.
Mousavizadeh A; Jabbari A; Akrami M; Bardania H
Colloids Surf B Biointerfaces; 2017 Oct; 158():507-517. PubMed ID: 28738290
[TBL] [Abstract][Full Text] [Related]
12. GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.
Zhao Y; Shi D; Shang M; Sun X; Guo L; Meng D; Liu X; Zhou X; Li J
Drug Deliv; 2022 Dec; 29(1):203-213. PubMed ID: 34985396
[TBL] [Abstract][Full Text] [Related]
13. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
[TBL] [Abstract][Full Text] [Related]
14. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
15. Albumin-templated platinum (II) sulfide nanodots for size-dependent cancer theranostics.
Li M; Wang Y; Li T; Zhang J; Wang X; Luo J; You M; Yang T; Deng Y; Yang H; Ke H
Acta Biomater; 2023 Jan; 155():564-574. PubMed ID: 36328127
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
Meng X; Wang J; Zhou J; Tian Q; Qie B; Zhou G; Duan W; Zhu Y
Acta Biomater; 2021 Jun; 127():266-275. PubMed ID: 33813091
[TBL] [Abstract][Full Text] [Related]
17. Innovative Diagnostic Peptide-Based Technologies for Cancer Diagnosis: Focus on EGFR-Targeting Peptides.
Ahmadi M; Ahmadyousefi Y; Salimi Z; Mirzaei R; Najafi R; Amirheidari B; Rahbarizadeh F; Kheshti J; Safari A; Soleimani M
ChemMedChem; 2023 Feb; 18(3):e202200506. PubMed ID: 36357328
[TBL] [Abstract][Full Text] [Related]
18. Ligand-targeted theranostic nanomedicines against cancer.
Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases.
Xia X; Wang Y; Zheng JC
Transl Neurodegener; 2022 Dec; 11(1):53. PubMed ID: 36510311
[TBL] [Abstract][Full Text] [Related]
20. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
